Asuragen Incorporated
At a glance
Employees100-499
In business sinceNot reported
HeadquartersAustin, TX
US patents31
SAM.gov UEIE8M9NXN4X4Y7
CAGE code4GGP6
Incorporated inDE
What they make
Bcr/Abl1 Monitoring TestGeneral Purpose ReagentGenetic Variant Detection And Health Risk Assessment SystemInherited Nucleotide Repeat Disorder Dna TestTissue Rna Preservative For Collection, Storage, And Transportation
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
31 US patents granted 2011–2024, 4 of them in the five years to SEP 2025.
Biotechnology 20Pharmaceuticals 10Computer technology 1
- Methods of RNA amplificationUS 12,139,755 · granted NOV 12, 2024
- Methods for nucleic acid size detection of repeat sequencesUS 11,913,068 · granted FEB 27, 2024
- Methods of RNA amplificationUS 11,236,384 · granted FEB 1, 2022
- Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating A/T-rich segmentsUS 11,214,829 · granted JAN 4, 2022
- Methods and compositions involving MicroRNAUS 10,047,388 · granted AUG 14, 2018
Newest 5 shown · Granted to Asuragen, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Asuragen Incorporated | Austin | TX | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.